4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001104659-22-029417
Director bought 441,865 shares at an average $12.95 ($5,721,951)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. Director | 2022-02-28 | Purchase | +8,746 | $12.97 | $113,430 | 11,082,163 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2022-03-01 | Purchase | +294,864 | $12.98 | $3,826,303 | 11,377,027 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2022-03-02 | Purchase | +138,255 | $12.89 | $1,782,218 | 11,515,282 | I |
| Open-market purchases · 441,865 sh · avg $12.95 · $5,721,951 | |||||||
Loading xslF345X03/tm228233-1_4seq1.xml…